Ginkgo Bioworks Holdings, Inc. (DNA) Social Stream
GINKGO BIOWORKS HOLDINGS INC (DNA) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering GINKGO BIOWORKS HOLDINGS INC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-15 | 2 | $14.5 | $14 | $14.25 | $2.74 | 420.07% |
| 2021-11-29 | 3 | $16 | $14 | $14.833 | $2.74 | 441.35% |
| 2021-12-14 | 3 | $14.5 | $14 | $14.166 | $2.74 | 417.01% |
| 2022-01-13 | 4 | $14.5 | $12 | $13.625 | $2.74 | 397.26% |
| 2022-01-18 | 4 | $14.5 | $11.5 | $13 | $2.74 | 374.45% |
| 2022-01-28 | 5 | $14.5 | $8 | $12 | $2.74 | 337.96% |
| 2022-02-01 | 5 | $14.5 | $6 | $11.6 | $2.74 | 323.36% |
| 2022-03-31 | 6 | $14.5 | $6 | $11.666 | $2.74 | 325.77% |
| 2022-04-04 | 6 | $14 | $6 | $10.166 | $2.74 | 271.02% |
| 2022-05-18 | 7 | $14 | $3 | $9.285 | $2.74 | 238.87% |
| 2022-08-16 | 7 | $14 | $3 | $8.264 | $2.74 | 201.61% |
The Trend in the Analyst Price Target
DNA's average price target has moved down $2.25 over the prior 138 days.
Over the past 43 weeks, DNA's average upside potential has been 128.02%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-15 | 3 | 14.5 | 14 | 14.250 | 12.97 | 9.87% |
| 2021-11-29 | 3 | 16.0 | 14 | 14.833 | 12.04 | 23.2% |
| 2021-12-14 | 4 | 14.5 | 14 | 14.166 | 9.50 | 49.12% |
| 2022-02-01 | 5 | 14.5 | 6 | 11.600 | 6.22 | 86.5% |
| 2022-04-04 | 7 | 14.0 | 6 | 10.166 | 4.13 | 146.15% |
DNA Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.86 | 4 | 1 | 1 | 0 | 0 | 7 |
The Trend in the Broker Recommendations
Over the past 122 days, DNA's average broker recommendation rating worsened by 0.36.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- GINKGO BIOWORKS HOLDINGS INC's upside potential (average analyst target price relative to current price) is greater than 1782.87% of all US stocks.
- In the context of stocks in the large market cap category, GINKGO BIOWORKS HOLDINGS INC's average analyst price target is higher than 89.48% of them.
- To contextualize these metrics, consider that out of stocks in the large market cap category, GINKGO BIOWORKS HOLDINGS INC's number of analysts covering the stock is greater than 165.35% of them.
- In terms of how GINKGO BIOWORKS HOLDINGS INC fares relative to stocks in the large market cap category, note that its variance in analysts' estimates is lower than -977.54% of that group.
In the Pharmaceutical Products industry, CRSP, BNTX, and BLUE are the three stocks most similar to GINKGO BIOWORKS HOLDINGS INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
What is the outlook for DNA? Use POWR Ratings for clearer insight into price direction.